Molekularna osnova odgovora na hemioradioterapiju u karcinomu rektuma, Strateški projekat Srpske akademije nauka i umetnosti, F-69, 2019-2022

Link to this page

Molekularna osnova odgovora na hemioradioterapiju u karcinomu rektuma, Strateški projekat Srpske akademije nauka i umetnosti, F-69, 2019-2022

Authors

Publications

Prognostic potential of circulating miR-93-5p in patients with colorectal liver metastases

Despotović, Jovana; Bogdanović, Aleksandar; Dragičević, Sandra; Galun, Danijel; Krivokapić, Zoran; Nikolić, Aleksandra

(EACR 2021 Virtual Congress: Innovative Cancer Science, 2021)

TY  - CONF
AU  - Despotović, Jovana
AU  - Bogdanović, Aleksandar
AU  - Dragičević, Sandra
AU  - Galun, Danijel
AU  - Krivokapić, Zoran
AU  - Nikolić, Aleksandra
PY  - 2021
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/1802
UR  - https://www.eacr2021.org/

https://fightcolorectalcancer.org/blog/recap-rally-on-research-eao-crc/
AB  - Approximately half of colorectal cancer (CRC) patients will develop liver metastases
(CRLM) during the course of the disease. Even with the use of modern adjuvant systemic treatment,
almost two thirds of metastatic colorectal cancer (mCRC) patients will eventually develop recurrent
disease after curative-intent surgery, thus the new prognostic biomarkers are necessary. The expression
signatures of microRNAs (miRNAs), a class of non-coding RNAs, have been associated with the
diagnosis, prognosis, and therapeutic response in CRC. The expression pattern and prognostic potential of
miR-93-5p has been studied previously in CRC but not in mCRC. The aim of this study was to examine
the expression pattern and prognostic potential of tumoral and circulating miR-93-5p in patients with
CRLM.
PB  - EACR 2021 Virtual Congress: Innovative Cancer Science
C3  - European Association for Cancer Research
T1  - Prognostic potential of circulating miR-93-5p in patients with colorectal liver metastases
UR  - https://hdl.handle.net/21.15107/rcub_imagine_1802
ER  - 
@conference{
author = "Despotović, Jovana and Bogdanović, Aleksandar and Dragičević, Sandra and Galun, Danijel and Krivokapić, Zoran and Nikolić, Aleksandra",
year = "2021",
abstract = "Approximately half of colorectal cancer (CRC) patients will develop liver metastases
(CRLM) during the course of the disease. Even with the use of modern adjuvant systemic treatment,
almost two thirds of metastatic colorectal cancer (mCRC) patients will eventually develop recurrent
disease after curative-intent surgery, thus the new prognostic biomarkers are necessary. The expression
signatures of microRNAs (miRNAs), a class of non-coding RNAs, have been associated with the
diagnosis, prognosis, and therapeutic response in CRC. The expression pattern and prognostic potential of
miR-93-5p has been studied previously in CRC but not in mCRC. The aim of this study was to examine
the expression pattern and prognostic potential of tumoral and circulating miR-93-5p in patients with
CRLM.",
publisher = "EACR 2021 Virtual Congress: Innovative Cancer Science",
journal = "European Association for Cancer Research",
title = "Prognostic potential of circulating miR-93-5p in patients with colorectal liver metastases",
url = "https://hdl.handle.net/21.15107/rcub_imagine_1802"
}
Despotović, J., Bogdanović, A., Dragičević, S., Galun, D., Krivokapić, Z.,& Nikolić, A.. (2021). Prognostic potential of circulating miR-93-5p in patients with colorectal liver metastases. in European Association for Cancer Research
EACR 2021 Virtual Congress: Innovative Cancer Science..
https://hdl.handle.net/21.15107/rcub_imagine_1802
Despotović J, Bogdanović A, Dragičević S, Galun D, Krivokapić Z, Nikolić A. Prognostic potential of circulating miR-93-5p in patients with colorectal liver metastases. in European Association for Cancer Research. 2021;.
https://hdl.handle.net/21.15107/rcub_imagine_1802 .
Despotović, Jovana, Bogdanović, Aleksandar, Dragičević, Sandra, Galun, Danijel, Krivokapić, Zoran, Nikolić, Aleksandra, "Prognostic potential of circulating miR-93-5p in patients with colorectal liver metastases" in European Association for Cancer Research (2021),
https://hdl.handle.net/21.15107/rcub_imagine_1802 .